INTODUCTION
The bile acid-activated farnesoid X receptor (FXR; NR1H4) is a member of the nuclear receptor superfamily that is expressed in liver, adrenals, kidney, small intestine, and colon (1) . Through FXR activation in the liver, bile acids induce transcription of the atypical nuclear receptor short heterodimer partner (NR0B2), which, in turn, represses transcription of the Cyp7a1 gene, encoding the rate-controlling enzyme in bile acid synthesis (2) . FXR also suppresses transcription of the gene encoding the hepatobiliary bile acid uptake transporter NTCP (Na + -taurocholate co transporting polypeptide; Slc10a1) and induces transcription of genes encoding canalicular bile acid transporters such as the bile salt export pump (ABCB11) and multidrug resistance protein-2 (ABCC2) (see reviews in Refs. (1) and (3)). In the intestine of mice, FXR stimulates transcription of the gene encoding the fibroblast growth factor 15 (4) . Fibroblast growth factor 15 reduces hepatic bile acid synthesis by repressing Cyp7a1 transcription in the liver. Apart from its clearly established effects on bile acid synthesis and transport, FXR is involved in the control of lipid and lipoprotein homeostasis. Fxr -/-mice have elevated plasma triglyceride and cholesterol levels (5;5), and FXR activation decreases plasma triglyceride levels in mice (6) . FXR negatively controls apoA-I (7) as well as apoC-III expression (6) , which contributes to FXR-mediated control of plasma lipid levels.
Recently, a link between FXR and glucose homeostasis has become evident. It was shown that glucose induces hepatic Fxr expression in rodent liver, probably via intermediates of the pentose-phosphate pathway (8) . Recent publications indicate that FXR plays a role in the regulation of the transcription of various hepatic carbohydrate metabolism-related genes. Activated FXR represses the transcription of gluconeogenic genes, e.g. those encoding phosphenolpyruvate carboxykinase, fructose-1,6-biphosphatase-1, and glucose-6-phosphatase (G6PC) in vitro (9) . In vivo experiments
showed that Fxr -/-mice have a reduced peripheral insulin sensitivity (10;11) and a reduced hepatic glucose production rate (12) .
Intestinal glucose transport is an important determinant of blood glucose levels.
After uptake of glucose by the enterocyte, glucose can take either a direct or an indirect pathway through the cell. In the indirect pathway, glucose is phosphorylated by hexokinase 1 or 2 (HK1 or HK2) into glucose-6-phosphate (G6P). The catalytic subunit of glucose-6-phosphatase (G6PC) dephosphorylates G6P and makes glucose available for transport across the basolateral membrane into the portal vein (13;14) . 
In Vivo Experiments

Oral Glucose Tolerance Test
After a 9 hour fast (11:00 pm to 8:00 am), the mice were given an oral glucose bolus of 5.6 ± 0.2 mmol.kg -1 in 0.2 ml of water under light isoflurane anesthesia. Blood glucose levels were determined in 2 µl of blood drawn from the tail with a handheld Lifescan EuroFlash glucose meter (Lifescan Benelux, Beerse, Belgium) at the indicated time points.
A similar experiment was conducted to determine the effect of the OGTT on plasma insulin levels. After a 9 hour fast (11:00 pm to 8:00 am), the mice were given an oral glucose bolus of 5.6 ± 0.2 mmol.kg -1 in 0. water was given under light isoflurane anesthesia at 2 hour after start of the infusion. At indicated time points, the blood glucose levels were determined in 2 µl of blood with a handheld Lifescan EuroFlash glucose meter, and 10 µl of blood spots were taken from the tail on filter paper for analysis of isotopic enrichments (18) . At the end of the experiment, the mice were killed by cardiac puncture under isoflurane anesthesia. The blood and livers were collected for further analysis.
Short Term Oral Glucose Tolerance Test
After a 9 hour fast (11:00 p.m. to 8:00 a.m.), the mice were either not treated or were
given an oral glucose bolus of 11.2 ± 0.2 mmol.kg -1 in 0.2 ml of water under light isoflurane anesthesia. After 30 min, the mice were killed by cardiac puncture under isoflurane anesthesia. The blood and livers were collected for further analysis. Small intestines were removed and rinsed with 10 ml of saline and divided into three equal sections. The samples were taken from the very first part of the intestine and from the middle of each intestinal section for measurements of mRNA expression level and metabolite concentrations.
Single-pool, First Order Kinetic Model
The excess fractional distribution of mass isotopologues was used to calculate the first order absorption process in a one-compartment model (19) (20) (21) Table S1 .
Analysis
For all analytical procedures see Appendix 2.
For correct gene names see Chapter 2.
Calculations
Equations used for the calculations of hepatic carbohydrate fluxes in non-steady-state situations are presented in Chapter 4.
Statistics
All of the values are expressed as the means ± S.E.. Statistical differences were determined using one-way analysis of variance or Mann-Whitney U test (metabolite concentrations and gene expression data). p < 0.05 was considered significant.
RESULTS
Fxr -/-Mice Show an Altered Plasma Glucose Response during an OGTT
Although fed male Fxr -/-mice and wild-type littermates had comparable body weights, there was a small but statistically significant difference in weight loss upon 9 hour of fasting between both groups (Table 1 ). Blood glucose levels were significantly lower in shows the averages of data points and estimated curves, whereas the estimated and derived parameters are presented in Table 2 . , p < 0.05) (Fig. 3A) . , Fxr -/-versus wild type, p < 0.05) (Fig. 3B ). In addition, the decline of glucose rate of appearance to baseline values was slower in Fxr -/-mice.
Because the oral glucose bolus contained a different stable isotope of glucose than the infusate, we were able to calculate the appearance rate of glucose derived from the intestine. Wild-type mice showed a steep, isolated peak in intestinal glucose absorption, whereas Fxr -/-mice showed a blunted absorption rate with a much slower decrease to baseline (Fig. 3C) . In Fxr -/-mice, the reduced recovery of intestine-derived glucose in the first 45 min after the oral glucose bolus was fully compensated for in the period thereafter (Fig. 3D) . Altogether, this resulted in similar recoveries at the end of the test.
These data show that Fxr -/-mice had delayed but not reduced intestinal glucose absorption after OGTT.
The difference between the total rate of glucose appearance and the appearance of intestine-derived glucose gives the EGP. Baseline EGP was significantly lower in Fxr -/-mice than in wild-type mice (Fig. 3E) . The EGP was significantly reduced in both groups upon administration of the glucose bolus, but the reduction was more pronounced in wild-type mice. The relative reduction was 50 ± 3% versus 30 ± 4% in wild-type and Fxr -/-mice, respectively. This latter observation of reduced reduction in EGP is inconsistent with our third hypothesis that EGP could be more reduced upon the OGTT in Fxr -/-than in wild-type mice.
Reduced Intestinal Glucose Absorbance in Fxr -/-Mice Is Likely the Result of Increased Glucose Phosphorylation in Proximal Enterocytes
From the three proposed mechanisms that might explain the delayed increase of blood glucose in Fxr -/-mice upon the OGTT, only a delayed intestinal glucose absorption rate seems to be valid. We next tried to unravel the cause of this hampered glucose absorption and tested whether enterocytic glucose handling might be disturbed in Fxr -/-mice. Therefore, glucose, glycogen, and G6P contents in the liver and small intestine were measured after the absorptive phase of the OGTT. The animals were sacrificed when the blood glucose values reached their peak value (30 min after glucose administration) or at the end of the test (180 min after glucose administration). At both time points hardly any administered glucose was found in the intestinal lumen of both groups, indicating a complete uptake in all mice (Fig. 4A) .
Fxr -/-mice had lower hepatic glycogen and G6P contents than wild-type mice 30 min after the oral glucose bolus (Fig. 4 , B and C). In 9 hour fasted mice, G6P concentrations in the proximal section of the small intestine were lower in the Fxr -/-mice than in wildtype mice (Fig. 4D) . Enterocyte G6P concentrations were not affected by the OGTT in Figure 5 . Gene expression profiles of the small intestine. Gene expressions of enzymes involved in intestinal glucose metabolism in ninehour fasted male wild-type and Fxr -/-mice. Relative mRNA expression was measured by real time PCR as described in Appendix 2. The results are normalized to β-actin and to the most proximal part of the wild type mice. Sglt1, sodiumdependent glucose/galactose transporter-1; Glut2, glucose transporter-2; G6pc, glucose-6-phosphatase, catalytic subunit; G6pt, glucose-6-phosphatase, transporter 1. The values are averages ± S.E. (n = 5). *, p < 0.05 between genotypes.
wild-type mice. In Fxr -/-mice, however, they significantly increased to values comparable with that of wild-type mice.
Next, we compared the expression of genes encoding proteins involved in intestinal glucose absorption and metabolism in sequential parts of the small intestine.
Expression patterns of the gene encoding the brush border located sodium-dependent glucose/galactose transporter 1 (SGLT1; Slc5A1) and the basolaterally located GLUT2
(glucose transporter-2; Slc2A2) was similar in the Fxr -/-and wild-type mice (Fig. 5, A and   B ). Compared with wild-type mice, the expression of the genes encoding the glucosephosphorylating enzymes HK1 and HK2 was significantly increased in the proximal part of the small intestine of Fxr -/-mice (Fig. 5, C and D) . Expression of G6pc and the gene encoding glucose-6-phosphatase, transporter 1 (G6pt; Slc37a4) did not differ between both genotypes, although both tended to be lower in Fxr -/-mice compared with wild type (Fig. 5, E and F) . Combined, these data suggest that delayed glucose passage through proximal enterocytes of Fxr -/-mice is likely the result of an increased glucose phosphorylation.
Diverted Glucose Flux through G6P Pool in Enterocytes of Fxr -/-Mice
The metabolic and gene expression data are indicative for an enhanced flux of glucose through G6P in the enterocyte of Fxr -/-mice compared with wild-type mice. We therefore considered it feasible to address the process of intestinal glucose absorption using a compartmental model (build using SAAM II software) comprising the direct (without intracellular metabolism) and indirect pathways (comprising the HK and G6Pase reactions) ( .min -1 ) in the Fxr -/-mice (Fig. 6C) . In contrast to the decreased direct flux in Fxr -/-mice, the values for the flux through both the HK and G6Pase was increased in the Fxr -/-mice. (Fig. 6, D and E) . The sum of the direct and G6Pase fluxes representing the total flux resulted in a glucose flux that is clearly reduced in Fxr -/-mice (Fig. 6F) , especially in the first 30 min after glucose administration. The compartmental model shows that the D-[U-
13
C]-glucose disposal rate was initially lower in Fxr -/-mice but was compensated at the end of the experiment (Fig. 6G) . It can be concluded from this simulation study that in enterocytes of wild-type mice glucose is absorbed preferentially by the direct pathway. In enterocytes of Fxr -/-mice, the indirect pathway becomes equally important. The values are averages (n = 5).
DISCUSSION
FXR is a bile acid-activated nuclear receptor that regulates biosynthesis and enterohepatic transport of bile acids (3;4). Recently, it was shown that FXR mRNA levels and activity are regulated by glucose (8) . In addition, FXR controls expression of several genes encoding enzymes in gluconeogenesis, e.g. Pck1, Fbp1, and G6pc (9). These findings indicate a role for FXR in control of hepatic glucose metabolism, particularly during the fasting-feeding transition (12) . Recent reports showed the presence of FXR in the absorptive epithelium of the small intestine (15) . The results of the current study clearly show that Fxr -/-mice have delayed intestinal glucose absorption caused by an enhanced G6P turnover in the proximal enterocytes. Thus, these results add an extra regulatory role to FXR in the regulation of energy substrate metabolism.
We noticed a difference in blood glucose increase between wild-type and Fxr -/-mice during an OGTT (Fig. 1) . The increase in blood glucose was clearly delayed in Fxr Thus, compared with wild-type mice, Fxr -/-mice had a significantly increased blood glucose half-life. Therefore, our first hypothesis to explain the hampered increase in blood glucose upon an oral glucose bolus in Fxr -/-mice, i.e. an enhanced glucose disposal rate in these mice, has been falsified. Based on earlier work (10), this outcome was expected.
Using both D-[U- (Fig. 3) . Compared with wild type mice, Fxr -/-mice had a reduced appearance of glucose in the first 45 min, which was compensated in the period thereafter, resulting in recoveries that were almost the same between both genotypes at the end of the experiment (Fig. 3D ). This fits with the observation that hardly any glucose was left in the intestinal lumen at 30 and 180 min after oral glucose administration (Fig. 4A ). These data establish that Fxr -/-mice have a delayed but not a decreased glucose appearance rate.
Previously, Cariou et al. (12) showed that Fxr -/-mice had a reduced EGP compared with wild types, which we could confirm in our experiments (Fig. 3E) . The data from the current study suggest reduced hepatic insulin sensitivity because the suppression of the EGP upon the OGTT was less pronounced in Fxr -/-mice compared with wild-type mice (Fig. 3E) . Remarkably, the OGTT-mediated reductions of the EGP in Fxr -/-and wild-type mice (Fig. 3E ) were fully comparable with was seen before when hyperinsulinemic euglycemic clamp experiments were performed (12) . We also found a tendency toward increased plasma insulin concentrations in the Fxr -/-mice shortly after the OGTT (Fig. 1C) . For 1 h after the OGTT onwards, the plasma insulin levels were statistically significant increased in the Fxr -/-mice. The higher plasma insulin levels of Fxr -/-mice (Fig. 1C) coincided with lower liver glycogen and liver G6P concentrations (Fig. 4 , B and C), again pointing toward a reduced hepatic insulin sensitivity. In addition, the increased blood glucose mean residence time in the sampled compartment (Table 2) in Fxr -/-mice point toward a reduced peripheral insulin sensitivity, as has also been shown before (10;11) . Thus, the current and previous studies (10) (11) (12) show reduced hepatic and peripheral insulin sensitivity in Fxr -/-mice.
From our initial hypotheses to explain the hampered increase in blood glucose during an OGTT in Fxr -/-mice, only a delayed appearance of intestine-derived glucose in Fxr -/-mice holds. This delayed appearance can be explained by a delayed glucose transport through the enterocyte and/or enhanced absorption of portal glucose by the liver. The latter is unlikely in view of the reduced hepatic glycogen and G6P
concentrations at 30 min after the oral glucose dose (Fig. 4 , B and C). We developed a compartmental model to simulate the consequences of an enhanced glucose metabolism inside enterocytes on the kinetics of glucose absorption. The model was based on the observations published by Stümpel et al. (13) . They showed that in isolated intestines of Glut2 -/-mice, addition of the G6Pase inhibitor S4048 almost completely abolished glucose transport across the intestinal wall. Apparently, when the direct transport of glucose across the intestinal wall via SGLT1 and Glut2 is absent, glucose transport proceeds by means of an indirect pathway involving glucose phosphorylation/dephosphorylation inside enterocytes. When this model is applied using our glucose data, it becomes clear that Fxr -/-mice have an enhanced flux through the enterocytic G6P pool compared with wild-type mice (Fig. 6, D and F ). An enhanced enterocyte glucose cycling is supported by the observation that the oral glucose administration resulted in a 6-fold increase of G6P in the proximal part of the small intestine in Fxr -/-mice, whereas this increase was absent in wild-type mice (Fig. 4D) . The increased Hk1 and Hk2 mRNA levels in the proximal part of the small intestine in Fxr The presence of FXR in tissues that are normally not exposed to bile acids, e.g. adipose tissue, adrenal glands, and skin (15) , suggests the existence of alternative endogenous FXR ligands.
In conclusion, the experiments described in this paper show that Fxr -/-mice have delayed intestinal glucose absorption, supporting a novel regulatory role of FXR in the enterocyte. Once again, these studies show that bile acid, carbohydrate, and lipid metabolism are closely linked. In addition, this paper shows the feasibility of the single pool, first order kinetic model to study kinetics of intestinal glucose absorption and processing with stable isotopes.
